株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

移植の世界市場:2019 - 2029年

Global Transplant Market Forecast 2019-2029

発行 Visiongain Ltd 商品コード 783075
出版日 ページ情報 英文 184 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=139.15円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
移植の世界市場:2019 - 2029年 Global Transplant Market Forecast 2019-2029
出版日: 2018年12月18日 ページ情報: 英文 184 Pages
概要

2019年における世界の移植市場規模は290億米ドルへ達すると予測され、2018年から2029年にかけては9.9%のCAGR (年間複合成長率) で拡大する見込みです。

当レポートでは、世界の移植市場について調査分析し、概要、市場予測、二次市場予測、地域別の市場予測、主要企業など、体系的な情報を提供しています。

第1章 レポートの概要

第2章 移植のイントロダクション

  • 移植とは?
  • 移植法とは?
  • 臓器拒絶反応とは?
  • 臓器・組織移植の歴史
  • 移植の種類
    • 自家移植
    • 同種間移植
    • 異種移植
  • 移植に関わるリスク
  • 主要諸国における臓器移植手術数
    • 米国
    • カナダ
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • 日本
    • 中国
    • ブラジル
    • メキシコ
    • 南アフリカ
    • ロシア
  • 人的・経済的な負担
    • 罹患率・死亡率
    • 経済的な影響

第3章 世界の移植市場規模・予測

第4章 世界の移植市場規模・予測:製品別

  • 細胞製品
  • 免疫抑制薬
  • 保存液

第5章 世界の移植市場規模・予測:用途別

  • 組織移植
    • 心臓弁置換
    • 血管移植片置換
    • 角膜移植
    • 皮膚移植片移植
    • 骨髄移植
    • その他の組織移植
  • 臓器移植
    • 腎臓移植
    • 肝臓移植
    • 心臓移植
    • 肺移植
    • 膵臓移植
    • その他臓器移植

第6章 世界の移植市場規模・予測:エンドユーザー別

  • 病院
  • 移植センター
  • その他

第7章 移植市場の情勢

  • 市場成長促進要因
  • 市場成長阻害要因

第8章 世界の移植市場規模・予測:地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • その他
  • その他 (RoW)
    • ブラジル
    • メキシコ
    • ロシア
    • 南アフリカ
    • その他

第9章 主要企業

  • Zimmer Biomet
    • 概要
    • 主要製品
    • 近年の発展
    • SWOT分析
  • AbbVie Inc.
  • Teva Pharmaceuticals
  • Novartis AG
  • Medtronic
  • Arthrex
  • Stryker Corporation
  • Veloxis Pharmaceuticals

第10章 その他の有望企業

第11章 結論

付録

図表

List of Tables

  • Table 2.1: Organ Transplant Procedure Average Cost
  • Table 3.1: Global Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 4.1: Global Tissue Products Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 4.2: Global Immunosuppressive Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 4.3: Global Preservation Solutions Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.1: Global Tissue Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.2: Global Heart Valve Replacement Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.3: Global Vascular Grafts Replacement Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.4: Global Bone Grafts Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.5: Global Cornea Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.6: Global Skin Grafts Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.7: Global Bone Marrow Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.8: Global Other Tissue Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.9: Global Organ Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.10: Global Kidney Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.11: Global Liver Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.12: Global Heart Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.13: Global Lung Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.14: Global Pancreas Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 5.15: Global Other Organ Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Figure 6.1: Global Transplant Market Segmentation by End-User
  • Table 6.1: Global Hospital Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 6.2: Global Transplant Centers Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 6.3: Global Others End Use Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.1: North America Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.2: North America Transplant Market by Product Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.3: North America Transplant Market by Application Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.4: North America Tissue Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.5: North America Organ Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.6: North America Transplant Market by End-User Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.7: U.S Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.8: Canada Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.9: Europe Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.10: Europe Transplant Market by Product Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.11: Europe Transplant Market by Application Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.12: Europe Tissue Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.13: Europe Organ Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.14: Europe Transplant Market by End-User Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.15: Germany Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.16: UK Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.17: France Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.18: Italy Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.19: Spain Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.20: Rest of Europe Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.21: Asia-Pacific Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.22: Asia-Pacific Transplant Market by Product Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.23: Asia-Pacific Transplant Market by Application Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.24: Asia-Pacific Tissue Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.25: Asia-Pacific Organ Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.26: Asia-Pacific Transplant Market by End-User Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.27: Japan Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.28: China Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.29: India Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.30: Rest of Asia-Pacific Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.31: RoW Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.32: RoW Transplant Market by Product Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.33: RoW Transplant Market by Application Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.34: RoW Tissue Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.35: RoW Organ Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.36: RoW Transplant Market by End-User Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.37: Brazil Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.38: Mexico Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.39: Russia Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.40: South Africa Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 8.41: Rest of RoW Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
  • Table 9.1: Zimmer Biomet: Overview
  • Table 9.2: Zimmer Biomet: Leading Products
  • Table 9.3: AbbVie Inc.: Overview
  • Table 9.4: AbbVie Inc.: Leading Products
  • Table 9.5: Teva Pharmaceuticals: Overview
  • Table 9.6: Teva Pharmaceuticals: Leading Products
  • Table 9.7: Novartis AG: Overview 2017
  • Table 9.8: Novartis AG: Leading Products
  • Table 9.9: Medtronic: Overview
  • Table 9.10: Medtronic: Leading Products
  • Table 9.11: Arthrex: Overview
  • Table 9.12: Arthrex: Leading Products
  • Table 9.13: Stryker Corporation: Overview
  • Table 9.14: Stryker Corporation: Leading Products
  • Table 9.15: Veloxis Pharmaceuticals: Overview
  • Table 9.16: Veloxis Pharmaceuticals: Leading Products
  • Table 10.1: List of Other Prominent Companies in the Transplant Market

List of Figures

  • Figure 2.1: Types of Transplant
  • Figure 2.2: Registered diabetes people in England in 2016 by gender
  • Figure 2.3: Number of Transplant Procedures (2012-2017)
  • Figure 2.4: Number of Transplant Procedures (2012-2017)
  • Figure 2.5: Number of Transplant Procedures (2012-2017)
  • Figure 2.6: Number of Transplant Procedures (2012-2017)
  • Figure 2.7: Number of Transplant Procedures (2012-2017)
  • Figure 2.8: Number of Transplant Procedures (2012-2017)
  • Figure 2.9: Number of Transplant Procedures (2012-2017)
  • Figure 2.10: Number of Transplant Procedures (2012-2017)
  • Figure 2.11: Number of Transplant Procedures (2015-2016)
  • Figure 2.12: Number of Transplant Procedures (2012-2017)
  • Figure 2.13: Number of Transplant Procedures (2012-2017)
  • Figure 2.14: Number of Transplant Procedures (2012-2016)
  • Figure 2.15: Number of Transplant Procedures (2012-2017)
  • Figure 4.1: Global Transplant Market Segmentation by Product
  • Figure 5.1: Global Transplant Market Segmentation by Application
  • Figure 5.2: Global Tissue Transplant Market Segmentation by Type
  • Figure 5.3: Global Organ Transplant Market Segmentation by Type Revenue (%), 2017-2029
  • Figure 7.1: Transplant Market Landscape
  • Figure 8.1: Global Transplant Market by Regional Breakdown: Revenue ($bn), 2017-2029
  • Figure 8.2: Global Transplant Market by Regional Breakdown:
  • Figure 8.3: Global Transplant Market by Regional Market Share (%), 2017
  • Figure 8.4: Global Transplant Market by Regional Market Share (%), 2023
  • Figure 8.5: Global Transplant Market by Regional Market Share (%), 2029
  • Figure 8.6: North America Transplant Market by Regional Breakdown: Revenue ($bn), 2017-2029
  • Figure 8.7: North America Transplant Market by Regional Breakdown: Revenue (%), 2017 & 2029
  • Figure 8.8: North America Transplant Market by Product (% Share): 2017, 2023, & 2029
  • Figure 8.9: North America Transplant Market by Application (% Share): 2017, 2023, & 2029
  • Figure 8.10: North America Transplant Market by End-User (% Share): 2017, 2023, & 2029
  • Figure 8.11: Europe Transplant Market by Regional Breakdown: Revenue ($bn), 2017-2029
  • Figure 8.12: Europe Transplant Market by Regional Breakdown: Revenue (%), 2017, 2023, & 2029
  • Figure 8.13: Europe Transplant Market by Product (% Share), 2017, 2023, & 2029
  • Figure 8.14: Europe Transplant Market by Application (% Share), 2017, 2023, & 2029
  • Figure 8.15: Europe Transplant Market by End-User (% Share), 2017, 2023, & 2029
  • Figure 8.16: Asia-Pacific Transplant Market by Regional Breakdown: Revenue ($bn), 2017-2029
  • Figure 8.17: Asia-Pacific Transplant Market by Regional Breakdown: Revenue (%), 2017, 2023, & 2029
  • Figure 8.18: Asia Pacific Transplant Market by Product (% Share): 2017, 2023, & 2029
  • Figure 8.19: Asia-Pacific Transplant Market by Application (% Share): 2017, 2023, & 2029
  • Figure 8.20: Asia-Pacific Transplant Market by End-User (% Share): 2017, 2023, & 2029
  • Figure 8.21: RoW Transplant Market by Regional Breakdown: Revenue ($bn), 2017-2029
  • Figure 8.22: RoW Transplant Market by Regional Breakdown: Revenue (%), 2017, 2023, & 2029
  • Figure 8.23: RoW Transplant Market by Product (% Share): 2017, 2023, & 2029
  • Figure 8.24: RoW Transplant Market by Application (% Share): 2017, 2023, & 2029
  • Figure 8.25: RoW Transplant Market by End-User: (% Share), 2017, 2023, & 2029
  • Figure 9.1: Zimmer Biomet: SWOT Analysis
  • Figure 9.2: AbbVie Inc.: SWOT Analysis
  • Figure 9.3: Teva Pharmaceuticals: SWOT Analysis
  • Figure 9.4: Novartis AG: SWOT Analysis
  • Figure 9.5: Medtronic: SWOT Analysis
  • Figure 9.6: Arthrex: SWOT Analysis
  • Figure 9.7: Stryker: SWOT Analysis
  • Figure 9.8: Veloxis Pharmaceuticals: SWOT Analysis
  • Figure 11.1: Global Transplant Market: Market Opportunity by Region (% share) 2017 and 2029
  • Figure 11.2: Global Transplant Market: Market Opportunity by Application (% share) 2017 and 2029

COMPANIES LISTED:

  • 21st Century Medicine
  • Abbott Laboratories
  • AbbVie, Inc.
  • Accord Healthcare GmbH
  • Accord Healthcare Ltd.
  • AllCells LLC
  • Allergan
  • AlloSource, Inc.
  • AmerisourceBergen Corporation
  • Apaxis Medical, Inc.
  • Arthrex, Inc.
  • Astellas Pharma, Inc.
  • AveXis, Inc.
  • Avita Medical
  • B.Braun Melsungen
  • Bard Peripheral Vascular Inc.
  • Baxter International
  • BioLife Solutions
  • BioLifeSolutions, Inc
  • BioTime
  • Boston Scientific Corp.
  • Bridge to Life
  • Bristol-Myers Squibb
  • Calon Cardio
  • CardiacAssist Inc.
  • Cardinal Health, Inc.
  • Cayenne Medical Inc.
  • Chiesi Farmaceutici S.p.A.
  • Claris Lifesciences
  • Colibri Heart Valve, LLC.
  • Coloplast
  • CONMED
  • Convatec Inc
  • Cook Medical
  • Cryolife
  • Danaher Corporation
  • Dentsply International
  • DePuy Synthes
  • Dr. F. Köhler Chemie
  • Edwards Lifesciences Corp.
  • Envarsus XR
  • Exactech
  • F. Hoffmann-La Roche Ltd.
  • Forticell Bioscience
  • Genzyme
  • Genzyme Corporation
  • Getinge Group
  • GlaxoSmithKline Plc.
  • Globus Medical, Inc.
  • Harvard Apparatus Regenerative Technologies
  • HeartWare
  • HeartWare International Inc.
  • Hill-Rom Holdings, Inc.
  • Integra Lifescience
  • Johnson & Johnson
  • Junken Medical Co., Ltd.
  • Karl Storz GmbH & Co.
  • Kiadis Pharma
  • Koninklijke Philips N.V.
  • LeMagitre Vascular Inc.
  • Lifeblood Medical
  • Lifeline Scientific
  • Lonza Group Ltd.
  • McKesson Corporation
  • Medrotonic
  • Merck Millipore
  • Mylan Laboratories, Inc.
  • Novartis AG
  • Nuvasive, Inc.
  • Olympus Optical Co. Ltd.
  • Optum Inc.
  • Organogenesis, Inc.
  • Organovo
  • Orthofix Holdings, Inc.
  • Penumbra, Inc.
  • Pfizer, Inc.
  • Preservation Solutions, Inc.
  • Sanofi
  • Sanofi; Pfizer, Inc.
  • Sanofi-Aventis LLC.
  • Smith & Nephew plc
  • Specmed Medical
  • STEMCELL Technologies
  • STERIS plc
  • Stratatech Corp.
  • Straumann Holding AG.
  • Stryker
  • SynCardia Systems, LLC
  • Terumo Cardiovascular
  • Terumo Corporation
  • Terumo Medical Corp.
  • Teva Pharmaceuticals
  • Thoratec Corporation.
  • Tissue Regenix Group PLC
  • TTK Healthcare Ltd
  • Veloxis Pharmaceuticals
  • Wright Medical Group N.V.
  • Zimmer Biomet
  • Zoll Medical Corporation

List of Organizations Mentioned in the Report:

  • American Academy of Orthopaedic Surgeons
  • American Association of Tissue Banks (AATB)
  • Centers for Disease Control and Prevention
  • European Commission
  • Eurotransplant International Foundation (ET)
  • FDA
  • Groote Schur Hospital
  • Harvard University
  • Health Care Finance Administration (HCFA)
  • Hospital Universitari Vall d'Hebron
  • Japan Organ Transplant Network
  • Japanese Ministry of Health, Labour and Welfare
  • Johns Hopkins University School of Medicine
  • Ministry of Health (MoH)
  • National Central Cancer Registry of China
  • National Development and Reform Commission (NDRC)
  • Network of Organ Sharing (UNOS)
  • NHS Blood and Transplant
  • Stanford Medical Center
  • United States Department of Defense
  • United States Department of Veterans Affairs
  • University of Colorado
  • University of Mississippi
  • WHO
目次
Product Code: PHA0346

Title:
GLOBAL TRANSPLANT MARKET FORECAST 2019-2029
Tissue Products, Immunosuppressive Drugs, Preservation Solutions, Tissue Transplant, Organ Transplant, Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues, Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant, Hospitals, Transplant Centres, Other End-Users.

The global transplant market will reach $29bn in 2019 and is estimated to grow at a CAGR of 9.9% from 2018- 2029. Visiongain estimated that Germany will hold 7.3% of the global transplant market.

How this report will benefit you:

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 184-page report you will receive 82 tables and 55 figures- all unavailable elsewhere.

The 184-page report provides clear detailed insight into the transplant market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Transplant Market from 2019-2029

Forecast of the Global Transplant market by Product:

  • Tissue Products
  • Immunosuppressive Drugs
  • Preservation Solutions
  • Forecast of the Global Transplant market by Application:
  • Tissue Transplant: Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues
  • Organ Transplant: Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant

Forecast of the Global Transplant market by End-user:

  • Hospitals
  • Transplant Centers
  • Others

This report provides individual revenue forecasts to 2029 for these regional and national markets:

  • North America: US, Canada
  • EU: Germany, France, United Kingdom, Italy, Spain and rest of EU
  • Asia-Pacific: Japan, China, India and rest of Asia-Pacific
  • RoW: Brazil, Mexico, Russia, South Africa and rest of ROW

Our study discusses the selected leading companies that are the major players in the transplant market:

  • AbbVie, Inc.
  • Arthrex, Inc.
  • Medtronic
  • Novartis AG
  • Stryker
  • Teva Pharmaceuticals
  • Veloxis Pharmaceuticals
  • Zimmer Biomet

This study discusses the competitive landscape, including factors that drive and restrain the transplant market

This report also provides the number organ transplant procedures from 2012-2027 in selected countries:

  • The US
  • Canada
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Japan
  • China
  • Brazil
  • Mexico
  • South Africa
  • Russia

Visiongain's study is intended for anyone requiring commercial analyses for the transplant market. You find data, trends and predictions.

Buy our report today Global Transplant Market Forecast 2019-2029: Tissue Products, Immunosuppressive Drugs, Preservation Solutions, Tissue Transplant, Organ Transplant, Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues, Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant, Hospitals, Transplant Centres, Other End-Users.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Why You Should Read This Report
  • 1.2. How This Report Delivers
  • 1.3. Key Questions Answered by This Analytical Report Include:
  • 1.4. Who is This Report for?
  • 1.5. Methodology
    • 1.5.1. Primary Research
    • 1.5.2. Secondary Research
    • 1.5.3. Market Evaluation & Forecasting Methodology
  • 1.6. Frequently Asked Questions (FAQ)
  • 1.7. Associated Visiongain Reports
  • 1.8. About Visiongain

2. Introduction to Transplant

  • 2.1. What is Transplant?
  • 2.2. What is Transplantation?
  • 2.3. What is Organ Rejection?
  • 2.4. History of Organ and Tissue Transplant
  • 2.5. Types of Transplant
    • 2.5.1. Autotransplantation
    • 2.5.2. Allotransplantation
    • 2.5.3. Xenotransplantation
  • 2.6. Risks Associated with Transplantation
  • 2.7. Number of Organ transplant Procedures in Major Countries
    • 2.7.1. U.S.
    • 2.7.2. Canada
    • 2.7.3. Germany
    • 2.7.4. UK
    • 2.7.5. France
    • 2.7.6. Italy
    • 2.7.7. Spain
    • 2.7.8. Japan
    • 2.7.9. China
    • 2.7.10. Brazil
    • 2.7.11. Mexico
    • 2.7.12. South Africa
    • 2.7.13. Russia
  • 2.8. Humanistic and Economic Burden
    • 2.8.1. Morbidity and Mortality
    • 2.8.2. Economic Impact

3. Global Transplant Market Size and Forecast, 2019-2029

4. Global Transplant Market Size and Forecast by Product, 2019-2029

  • 4.1. Tissue Products
  • 4.2. Immunosuppressive Drugs
  • 4.3. Preservation Solutions

5. Global Transplant Market Size and Forecast by Application, 2019-2029

  • 5.1. Tissue Transplant
    • 5.1.1. Heart Valve Replacement
    • 5.1.2. Vascular Grafts Replacement
    • 5.1.3. Bone Grafts Transplantation
    • 5.1.4. Cornea Transplantation
    • 5.1.5. Skin Grafts Transplantation
    • 5.1.6. Bone Marrow Transplantation
    • 5.1.7. Other Tissues Transplant
  • 5.2. Organ transplant
    • 5.2.1. Kidney Transplant
    • 5.2.2. Liver Transplant
    • 5.2.3. Heart Transplant
    • 5.2.4. Lung Transplant
    • 5.2.5. Pancreas Transplant
    • 5.2.6. Other Organ Transplant

6. Global Transplant Market Size and Forecast by End-User, 2019-2029

  • 6.1. Hospitals
  • 6.2. Transplant Centers
  • 6.3. Others

7. Transplant Market Landscape

  • 7.1. Market Drivers
    • 7.1.1. Increased Incidence of Organ Failure
    • 7.1.2. Advances in Technology
    • 7.1.3. Initiatives by Government and NGO's to Create Awareness for Organ Donation
    • 7.1.4. Increased M&A and Strategic Collaboration
    • 7.1.5. Increased Healthcare Expenditure
    • 7.1.6. Developed Tissue banks
    • 7.1.7. Innovation of 3D Bioprinting
  • 7.2. Market Growth Inhibitors
    • 7.2.1. Transplant Rejection
    • 7.2.2. Intense Competition among Vendors
    • 7.2.3. Shortage of Organ Donors
    • 7.2.4. Ethical and Cultural Issues

8. Global Transplant Market Size and Forecast by Region, 2019-2029

  • 8.1. North America Transplant Market Forecast 2019-2029
    • 8.1.1. U.S. Transplant Market Forecast 2019-2029
    • 8.1.2. Canada Transplant Market Forecast 2019-2029
  • 8.2. Europe Transplant Market Forecast 2019-2029
    • 8.2.1. Germany Transplant Market Forecast 2019-2029
    • 8.2.2. UK Transplant Market Forecast 2019-2029
    • 8.2.3. France Transplant Market Forecast 2019-2029
    • 8.2.4. Italy Transplant Market Forecast 2019-2029
    • 8.2.5. Spain Transplant Market Forecast 2019-2029
    • 8.2.6. Rest of Europe Transplant Market Forecast 2019-2029
  • 8.3. Asia-Pacific Transplant Market Forecast 2019-2029
    • 8.3.1. Japan Transplant Market Forecast 2019-2029
    • 8.3.2. China Transplant Market Forecast 2019-2029
    • 8.3.3. India Transplant Market Forecast 2019-2029
    • 8.3.4. Rest of Asia-Pacific Transplant Market Forecast 2019-2029
  • 8.4. RoW Transplant Market Forecast 2019-2029
    • 8.4.1. Brazil Transplant Market Forecast 2019-2029
    • 8.4.2. Mexico Transplant Market Forecast 2019-2029
    • 8.4.3. Russia Transplant Market Forecast 2019-2029
    • 8.4.4. South Africa Transplant Market Forecast 2019-2029
    • 8.4.5. Rest of RoW Market Forecast 2019-2029

9. Leading Companies in the Global Transplant Market

  • 9.1. Zimmer Biomet
    • 9.1.1. Overview
    • 9.1.2. Leading Products
    • 9.1.3. Recent Developments
    • 9.1.4. SWOT Analysis
  • 9.2. AbbVie Inc.
    • 9.2.1. Overview
    • 9.2.2. Leading Products
    • 9.2.3. Strategic Planning
    • 9.2.4. SWOT Analysis
  • 9.3. Teva Pharmaceuticals
    • 9.3.1. Overview
    • 9.3.2. Leading Products
    • 9.3.3. Recent Developments
    • 9.3.4. SWOT Analysis
  • 9.4. Novartis AG
    • 9.4.1. Overview
    • 9.4.2. Leading Products
    • 9.4.3. Recent Developments
    • 9.4.4. SWOT Analysis
  • 9.5. Medtronic
    • 9.5.1. Overview
    • 9.5.2. Leading Products
    • 9.5.3. Recent Developments
    • 9.5.4. SWOT Analysis
  • 9.6. Arthrex
    • 9.6.1. Overview
    • 9.6.2. Leading Products
    • 9.6.3. Recent Developments
    • 9.6.4. SWOT Analysis
  • 9.7. Stryker Corporation
    • 9.7.1. Overview
    • 9.7.2. Leading Products
    • 9.7.3. Recent Developments
    • 9.7.4. SWOT Analysis
  • 9.8. Veloxis Pharmaceuticals
    • 9.8.1. Overview
    • 9.8.2. Leading Products
    • 9.8.3. Recent Developments
    • 9.8.4. SWOT Analysis

10. Other Prominent Companies

11. Conclusion

Appendices

  • Associated Reports
  • Report Sales Order Form
  • About Visiongain
  • Report Evaluation Form
Back to Top